{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-005534","form_type":"8-K","ticker":"APH","cik":"0000820313","company_name":"AMPHENOL CORP /DE/","filed_at":"2024-04-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.072671+00:00","generated_at":"2026-06-03T10:36:28.543621+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Amphenol Q1 sales up 9% to $3.26B, EPS $0.87; announces $2B share repurchase program","bullets":["Q1 GAAP diluted EPS $0.87 (+23% YoY); adjusted EPS $0.80 (+16%); sales $3.26B (+9%, +6% organic)","GAAP & adjusted operating margin 21.0%, a first-quarter record; operating cash flow $599M, free cash flow $506M","Board authorized new three-year, $2B open market stock repurchase program starting April 29, 2024","Q2 2024 guidance: sales $3.24-$3.30B; adjusted EPS $0.79-$0.81, representing 6-8% and 10-13% YoY growth respectively","Returned $286M to shareholders in Q1 via $154M share repurchases and $132M dividends"],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-005534","json":"https://secwatch.observer/filing/0001558370-24-005534.json","markdown":"https://secwatch.observer/filing/0001558370-24-005534.md","text":"https://secwatch.observer/filing/0001558370-24-005534.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/820313/000155837024005534/0001558370-24-005534-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/820313/000155837024005534/aph-20240424x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T10:36:28.543621+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"97387b2f0c9b407aa91aaf2b7e85ea4bf974f2f4","claim":"AMPHENOL CORP /DE/ reported the quarter ended March 31, 2024 results: revenue Sales of $3.26 billion, EPS GAAP Diluted EPS of $0.87.","evidence_excerpt":"CT 06492 Telephone (203) 265-8900 ​ ​ ​ AMPHENOL REPORTS FIRST QUARTER 2024 RESULTS AND ANNOUNCES NEW STOCK REPURCHASE PROGRAM ​ ​ First Quarter 2024 Highlights: ​ ● Sales of $3.26 billion, up 9% in U.S. dollars and 6% organically compared to the first quarter of 2023 ● GAAP Diluted EPS of $0.87, up 23% compared to prior year ● Adjusted Diluted EPS of $0.80, up 16%","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/820313/000155837024005534/0001558370-24-005534-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2024"},{"label":"Revenue","value":"Sales of $3.26 billion"},{"label":"EPS","value":"GAAP Diluted EPS of $0.87"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}